Alpha 2.0
Login Register
» Articles » PMID: 11698576

Re: Axillary Lymph Node Staging in Breast Cancer by 2-fluoro-2-deoxy-D-glucose-positron Emission Tomography: Clinical Evaluation and Alternative Management

Overview
Journal J Natl Cancer Inst
Publisher Oxford University Press
Specialty Oncology
Date 2001 Nov 8
PMID 11698576
Citations 3
Authors
H Torrenga
J Licht
J J van der Hoeven
O S Hoekstra
S Meijer
P J van Diest
Affiliations
Soon will be listed here.
Citing Articles

Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?.

Brouwer J, de Bree R, Comans E, Castelijns J, Hoekstra O, Leemans C Eur Arch Otorhinolaryngol. 2003; 261(9):479-83.

PMID: 14685887 DOI: 10.1007/s00405-003-0727-3.

How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma.

Mijnhout G, Hoekstra O, van Lingen A, van Diest P, Ader H, Lammertsma A J Clin Pathol. 2003; 56(4):283-6.

PMID: 12663640 PMC: 1769919. DOI: 10.1136/jcp.56.4.283.

Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer.

van der Hoeven J, Hoekstra O, Comans E, Pijpers R, Boom R, van Geldere D Ann Surg. 2002; 236(5):619-24.

PMID: 12409668 PMC: 1422620. DOI: 10.1097/00000658-200211000-00012.